Due to health issues, this site is no longer maintained and will be shut down shortly.

GNFT GENFIT S.A. ADRs

Develops biopharmaceutical products for the treatment of cardio metabolic and neurodegenerative diseases This is an ADR of a company whose stock trades outside of the U.S. as the symbol FP:GNFT.

$3.93  -0.15 (-3.56%)
As of 03/24/2023 16:00:00 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  France
Country of incorporation:  
IPO date:  01/27/2016
Outstanding shares:  49,834,983
Average volume:  5,128
Market cap:   $203,077,556
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Sedol:      
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy